# CAPTURE Study (Polyglucosamine for Cardio & Atherosclerosis Prevention and Treatment Via Fat Uptake REduction)

> **NCT06910111** · NA · NOT_YET_RECRUITING · sponsor: **Certmedica International GmbH** · enrollment: 240 (estimated)

## Conditions studied

- Atherosclerotic Disease

## Interventions

- **DEVICE:** Polyglucosamine
- **DEVICE:** Placebo

## Key facts

- **NCT ID:** NCT06910111
- **Lead sponsor:** Certmedica International GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-04-01
- **Primary completion:** 2026-12
- **Final completion:** 2027-03
- **Target enrollment:** 240 (ESTIMATED)
- **Last updated:** 2025-04-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06910111

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06910111, "CAPTURE Study (Polyglucosamine for Cardio & Atherosclerosis Prevention and Treatment Via Fat Uptake REduction)". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT06910111. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*